Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
330 participants
INTERVENTIONAL
2025-01-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Are the selected hearing screening methods effective in detecting hearing loss in the target population? Can these methods be successfully implemented within the national healthcare system to address gaps in current practices?
Participants will:
1. Undergo hearing screening using all three methods, conducted by general practitioners, to assess their performance.
2. Complete follow-up evaluations conducted by ENT specialists to confirm diagnostic results.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation and Evaluation of the French Version of a Hearing Loss Screening Questionnaire in Adults Aged 60 Years Old and More
NCT04159428
Hearing Aids Use in Elderly: Efficacy in Speech Perception and in Health-related Quality of Life
NCT04333043
Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
NCT04281953
Validation of uHear™ as a Screening Tool to Detect Hearing Impairment in Elderly Cancer Patients Within a Comprehensive Geriatric Assessment
NCT02381782
Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss
NCT05312983
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study Population and Interventions
Participants:
A total of 330 adults aged 50 years and older will be enrolled in the study.
Interventions:
The interventions are divided into two stages:
General Practitioners' Offices:
Before the screening:
Explanation of the screening process. Personal medical history review. Otoscopy and patient instruction.
Screening procedures (performed for all participants in the same order according to the standardized protocol):
1. Completion of the screening version of the standardized "HHIA" questionnaire (Czech version).
2. Whisper test conducted following the standardized protocol.
3. Screening pure tone audiometry performed according to the standardized protocol.
ENT Clinics:
Before the evaluation:
Explanation of the evaluation process. ENT-specific medical history review. Otoscopy and patient instruction.
Diagnostic procedures (performed for all participants in the same order according to the standardized protocol):
1. Pure tone audiometry conducted following the standardized protocol.
2. Tympanometry.
The findings will provide evidence for developing a comprehensive, national-scale hearing screening program for the aging population in the Czech Republic.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants
Participants over 50 years old.
Screening HHIA questionnaire
Completion of the abbreviated (screening) version of the standardized "HHIA" questionnaire (Czech version).
Whispered voice test
Whispered voice test conducted following the standardized protocol.
Screening pure tone audiometry
Screening pure-tone audiometry at a level of 35 dB at the frequencies: 500, 1000, 2000, and 4000 Hz.
Pure Tone Audiometry
Clinical Pure Tone Audiometry
Tympanometry
Clinical Tympanometry
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Screening HHIA questionnaire
Completion of the abbreviated (screening) version of the standardized "HHIA" questionnaire (Czech version).
Whispered voice test
Whispered voice test conducted following the standardized protocol.
Screening pure tone audiometry
Screening pure-tone audiometry at a level of 35 dB at the frequencies: 500, 1000, 2000, and 4000 Hz.
Pure Tone Audiometry
Clinical Pure Tone Audiometry
Tympanometry
Clinical Tympanometry
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 50 years or older.
Exclusion Criteria
* Inability to sufficiently understand study instructions due to language barriers.
* Medical condition preventing participation in all parts of the study.
* Inability or unwillingness to complete all parts of the study.
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Society of General Practice, J. E. Purkyne Czech Medical Association
UNKNOWN
Hospital Pardubice
UNKNOWN
University Hospital Hradec Kralove
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Viktor Chrobok, prof., M.D., CSc., Ph.D.
Role: STUDY_CHAIR
University Hospital Hradec Kralove
MUDr. Michal Homoláč
Role: PRINCIPAL_INVESTIGATOR
University Hospital Hradec Kralove
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Hradec Kralove
Hradec Králové, Czech Republic, Czechia
Pardubice Hospital
Pardubice, Czech Republic, Czechia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
WORLD HEALTH ORGANIZATION. Hearing Screening Considerations For Implementation. World Health Organization. 2021, 1-64.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202501 P01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.